Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice

Diabetes

Volumn 57, Issue 2, 2008, Pages 387-394

  Martin, Andrea P ^a   Grisotto, Marcos G ^a   Canasto Chibuque, Claudia ^a   Kunkel, Steven L ^b   Bromberg, Jonathan S ^a   Furtado, Glaucia C ^a   Lira, Sergio A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE DECOY RECEPTOR M3; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL DESTRUCTION; CELL INFILTRATION; CELL MATURATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; LEUKOCYTE; LYMPH NODE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; ANIMAL; BLOOD; C57BL MOUSE; CROSS BREEDING; DBA MOUSE; GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROMOTER REGION; RAT; SECRETION;

ANIMALS; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 1; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED NOD; MICE, SCID; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, CHEMOKINE;

EID: 40749154028     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1309     Document Type: Article

References (48)

1. Foulis AK: C.L. Oakley Lecture 1987. The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus. J Pathol 152:141-148, 1987
2. Adorini L, Gregori S, Harrison LC: Understanding autoimmune diabetes: insights from mouse models. Trends Mol Med 8:31-38, 2002
3. Wicker LS, Miller BJ, Mullen Y: Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35:855-860, 1986
4. Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada M: Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol 22:2387-2393, 1992
5. Nikolic T, Geutskens SB, van Rooijen N, Drexhage HA, Leenen PJ: Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study. Lab Invest 85:487-501, 2005
6. + T-cells in T-cell receptor transgenic NOD mice. Diabetes 48:34-42, 1999
7. Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, Hollander GA, Piali L: Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 8:1414-1420, 2002
8. Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L: A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol 173:2280-2287, 2004
9. Piemonti L, Leone BE, Nano R, Saccani A, Monti P, Maffi P, Bianchi G, Sica A, Peri G, Melzi R, Aldrighetti L, Secchi A, Di Carlo V, Allavena P, Bertuzzi F: Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 51:55-65, 2002
10. Cameron MJ, Arreaza GA, Grattan M, Meagher C, Sharif S, Burdick MD, Strieter RM, Cook DN, Delovitch TL: Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J Immunol 165:1102-1110, 2000
11. Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL: Monocyte chemoattractant protein-1 is expressed in pancreatic islets from predia-betic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia 44:325-332, 2001
12. Bouma G, Coppens JM, Mourits S, Nikolic T, Sozzani S, Drexhage HA, Versnel MA: Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice. Eur J Immunol 35:2386-2396, 2005
13. Ploix C, Lo D, Carson MJ: A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity. J Immunol 167:6724-6730, 2001
14. Kim SH, Cleary MM, Fox HS, Chantry D, Sarvetnick N: CCR4-bearing T cells participate in autoimmune diabetes. J Clin Invest 110:1675-1686, 2002
15. Savinov AY, Wong FS, Stonebraker AC, Chervonsky AV: Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J Exp Med 197:643-656, 2003
16. Szanya V, Ermann J, Taylor C, Holness C, Fathman CG: The subpopulation of CD4+ CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol 169:2461-2465, 2002
17. Jensen KK, Chen SC, Hipkin RW, Wiekowski MT, Schwarz MA, Chou CC, Simas JP, Alcami A, Lira SA: Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J Virol 77:624-630, 2003
18. Martin AP, Alexander-Brett JM, Canasto-Chibuque C, Garin A, Bromberg JS, Fremont DH, Lira SA: The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin. J Immunol 178:4623-4631, 2007
19. Andre I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D: Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci USA 93:2260-2263, 1996
20. Ikegami H: Animal models of autoimmune polyglandular syndrome. Endocrinol Metab Clin North Am 31:431-439, viii, 2002
21. Kikutani H, Makino S: The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51:285-322, 1992
22. Morimoto J, Yoneyama H, Shimada A, Shigihara T, Yamada S, Oikawa Y, Matsushima K, Saruta T, Narumi S: CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis. J Immunol 173:7017-7024, 2004
23. Miyagawa J, Hanafusa T, Miyazaki A, Yamada K, Fujino-Kurihara H, Nakajima H, Kono N, Nonaka K, Tochino Y, Tarui S: Ultrastructural and immunocytochemical aspects of lymphocytic submandibulitis in the non-obese diabetic (NOD) mouse. Virchows Arch B Cell Pathol Incl Mol Pathol 51:215-225, 1986
24. Zhang Y, O'Brien B, Trudeau J, Tan R, Santamaria P, Dutz JP: In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol 168:1466-1472, 2002
25. Mathis D, Vence L, Benoist C: Beta-cell death during progression to diabetes. Nature 414:792-798, 2001
26. Haskins K, Portas M, Bradley B, Wegmann D, Lafferty K: T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37:1444-1448, 1988
27. Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D: Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189:331-339, 1999
28. Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL: IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46:255-266, 2003
29. Janatpour MJ, Hudak S, Sathe M, Sedgwick JD, McEvoy LM: Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J Exp Med 194:1375-1384, 2001
30. Chen SC, Vassileva G, Kinsley D, Holzmann S, Manfra D, Wiekowski MT, Romani N, Lira SA: Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J Immunol 168:1001-1008, 2002
31. Christen U, McGavern DB, Luster AD, von Herrath MG, Oldstone MB: Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol 171:6838-6845, 2003
32. Shigihara T, Shimada A, Oikawa Y, Yoneyama H, Kanazawa Y, Okubo Y, Matsushima K, Yamato E, Miyazaki J, Kasuga A, Saruta T, Narumi S: CXCL10 DNA vaccination prevents spontaneous diabetes through enhanced beta cell proliferation in NOD mice. J Immunol 175:8401-8408, 2005
33. Carvalho-Pinto C, Garcia MI, Gomez L, Ballesteros A, Zaballos A, Flores JM, Mellado M, Rodriguez-Frade JM, Balomenos D, Martinez AC: Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. Eur J Immunol 34:548-557, 2004
34. van Berkel V, Barrett J, Tiffany HL, Fremont DH, Murphy PM, McFadden G, Speck SH, Virgin HI: Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol 74: 6741-6747, 2000
35. Parry CM, Simas JP, Smith VP, Stewart CA, Minson AC, Efstathiou S, Alcami A: A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191:573-578, 2000
36. Alexander JM, Nelson CA, van Berkel V, Lau EK, Studts JM, Brett TJ, Speck SH, Handel TM, Virgin HW, Fremont DH: Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111:343-356, 2002
37. Webb LM, Clark-Lewis I, Alcami A: The gammaherpesvirus chemokine binding protein binds to the N terminus of CXCL8. J Virol 77:8588-8592, 2003
38. van Berkel V, Levine B, Kapadia SB, Goldman JE, Speck SH, Virgin HWT: Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J Clin Invest 109:905-914, 2002
39. Pyo R, Jensen KK, Wiekowski MT, Manfra D, Alcami A, Taubman MB, Lira SA: Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3. Am J Pathol 164:2289-2297, 2004
40. Liu L, Dai E, Miller L, Seet B, Lalani A, Macauley C, Li X, Virgin HW, Bunce C, Turner P, Moyer R, McFadden G, Lucas A: Viral chemokine-binding proteins inhibit inflammatory responses and aortic allograft transplant vasculopathy in rat models. Transplantation 77:1652-1660, 2004
41. Martin AP, Canasto-Chibuque C, Shang L, Rollins BJ, Lira SA: The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo. J Immunol 177:7296-7302, 2006
42. Levisetti MG, Suri A, Frederick K, Unanue ER: Absence of lymph nodes in NOD mice treated with lymphotoxin- βreceptor immunoglobulin protects from diabetes. Diabetes 53:3115-3119, 2004
43. Gagnerault MC, Luan JJ, Lotton C, Lepault F: Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J Exp Med 196:369-377, 2002
44. Jun HS, Yoon CS, Zbytnuik L, van Rooijen N, Yoon JW: The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 189:347-358, 1999
45. Iyoda T, Shimoyama S, Liu K, Omatsu Y, Akiyama Y, Maeda Y, Takahara K, Steinman RM, Inaba K: The CD8+ dendritic cell subset selectively endo-cytoses dying cells in culture and in vivo. J Exp Med 195:1289-1302, 2002
46. Turley S, Poirot L, Hattori M, Benoist C, Mathis D: Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med 198:1527-1537, 2003
47. Harbers SO, Crocker A, Catalano G, D'Agati V, Jung S, Desai DD, Clynes R: Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J Clin Invest 117:1361-1369, 2007
48. Wells TN, Power CA, Shaw JP, Proudfoot AE: Chemokine blockers: therapeutics in the making? Trends Pharmacol Sci 27:41-47, 2006